The Annals of Internal Medicine published an intriguing essay online last week about tight glycemic control in type 2 diabetes. Its authors argue that we’ve got it all wrong: imposing tight controls is only subjecting patients to stresses — related to the complexities and costs of treatment — that make control less likely to succeed. In addition, the supposed benefits of that control haven’t been confirmed by the available evidence. They advocate a backing-off of the current stern limits, which might make visits ...
The
Annals of Internal Medicine published an intriguing essay online last week about tight glycemic control in type 2 diabetes. Its authors argue that we’ve got it all wrong: imposing tight controls is only subjecting patients to stresses — related to the complexities and costs of treatment — that make control less likely to succeed. In addition, the supposed benefits of that control haven’t been confirmed by the available evidence. They advocate a backing-off of the current stern limits, which might make visits to clinicians feel less like a visit to the principal’s office. Listen in on a conversation with Dr. Victor Montori, one of the essay’s coauthors.
As always, you are invited to weigh in with your own thoughts. Leave us a piece of your mind at 1-617-440-4374.
This week’s links:
- A Skeptical Look at Tight Glycemic Control
- Resources mentioned by Dr. Montori in the interview
- Additional Swine Flu Cases Found, CDC Says
- FDA Allows OTC ‘Morning-After Pill’ for 17-Year-Olds
The post Podcast 40: Tight control in type 2 diabetes — time to loosen up? A conversation with Mayo’s Victor Montori. first appeared on Clinical Conversations.
View more